FellowshipTransforming breakthrough science into high-impact biotech companies.

Persephoni BioPartners is a biotechnology venture studio based in the United States, focused on transforming early-stage scientific breakthroughs into therapeutics. It partners with innovators and academic institutions to build high-impact biotech companies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Persephoni BioPartners is a biotechnology venture studio that partners with innovators at the earliest stages to transform scientific breakthroughs into real-world therapeutics. Founded by Hilary Schultz, the organization is based in the United States and focuses on building high-impact biotech companies by collaborating with academic institutions, investors, and industry leaders.
Persephoni BioPartners invests in early-stage biotech companies rooted in biology with the potential to impact human health through therapeutic, diagnostic, or platform-based innovations. The organization prioritizes ventures with robust intellectual property and scalable business models designed for long-term growth, focusing on areas such as autoimmunity, oncology, and viral diseases.
Persephoni BioPartners offers hands-on company formation, operational support, capital access, and partnership-building to help innovators translate scientific inventions into viable biotech companies.
Persephoni focuses on early-stage biotech companies with a strong foundation in biology.
The organization provides operational support, capital access, and partnership-building to help companies grow.
Superscout Pro
Is this page right?Reviewed · How the research works